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Dihydrotestosterone stimulates amino acid uptake and
the expression of LAT2 in mouse skeletal muscle fibres
through an ERK1/2-dependent mechanism
M. M. Hamdi and G. Mutungi
Biomedical and Clinical Sciences Research Institute, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ, UK
Non technical summary In a recent study we showed that dihydrotestosterone (DHT), but
not testosterone, increases force production in fast contracting muscles and decreases it in slow
contracting ones. These findings led us to suggest that DHT may be a better muscle building
hormone than testosterone. In the present study, we have examined the effects of these hormones
on amino acid transport in mouse fast and slow contracting skeletal muscle fibre bundles. Our
results show that DHT increases protein synthesis and the transport of essential amino acids into
fast contracting muscle fibre bundles, whereas testosterone does not. These findings confirm our
previous proposition and reinforce our suggestion that DHT may be a better hormone for the
treatment of muscle wasting conditions than testosterone.
Abstract Dihydrotestosterone (DHT) has acute/non-genomic actions in adult mammalian
skeletalmuscles whose physiological functions are still poorly understood. Therefore, the primary
aim of this study was to investigate the acute/non-genomic effects of DHT on amino acid uptake
as well as the cellular signal transduction events underlying these actions in mouse fast- and
slow-twitch skeletal muscle fibre bundles. 14C-Labelled amino acids were used to investigate the
effects of DHT and testosterone (T) on amino acid uptake and pharmacological interventions
were used to determine the cellular signal transduction events mediating these actions. While
T had no effect on the uptake of isoleucine (Ile) and α-methylaminoisobutyric acid (MeAIB)
in both fibre types, DHT increased their uptake in the fast-twitch fibre bundles. This effect was
reversed by inhibitors of protein translation, the epidermal growth factor receptor (EGFR), system
A, system L, mTOR andMEK. However, it was relatively insensitive to inhibitors of transcription,
androgen receptors and PI3K/Akt. Additionally, DHT treatment increased the expression of LAT2
and the phosphorylation of the EGFR in the fast-twitch fibre bundles and that of ERK1/2, RSK1/2
and ATF2 in both fibre types. Also, it decreased the phosphorylation of eEF2 and increased the
incorporation of Ile into proteins in both fibre types. Most of these effects were reversed by EGFR
and MEK inhibitors. From these findings we suggest that another physiological function of the
acute/non-genomic actions of DHT in isolated mammalian skeletal muscle fibres is to stimulate
amino acid uptake. This effect is mediated through the EGFR and involves the activation of the
MAPK pathway and an increase in LAT2 expression.
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Introduction
Dihydrotestosterone (DHT) is a metabolite of the male
sex hormone testosterone (T) that is produced in many
tissues following the rapid and irreversible reduction
of T by 5α-reductase (Bruchovsky & Wilson, 1968).
Although the free plasma concentration of DHT and
T (normal range 1.5–20 ng dl−1 and 4–57.5 ng dl−1 for
testosterone and DHT, respectively) in healthy young
adult men is similar, it is generally accepted that DHT
is the more potent hormone because of its receptor
binding kinetics (Saartok et al. 1984). However, as the
expression of 5α-reductase in adult mammalian skeletal
muscles is still controversial, it has been suggested that
DHTmay not have any physiological functions in skeletal
muscle (Thigpen et al. 1993). Nevertheless, in a recent
study we showed that DHT, but not T, modulates force
production in isolated intact mouse skeletal muscle
fibres. These effects were mediated through the EGFR
and involved the activation of ERK1/2. From these
findings we suggested that DHT may be the more potent
anabolic–androgenic steroid (AAS) in adult mammalian
skeletalmuscle fibres (Hamdi&Mutungi, 2010).However,
whether DHT has any other acute/non-genomic physio-
logical functions in mammalian skeletal muscles is
uncertain.
In adult males, AASs are important determinants of
body composition (Wilson et al. 1988; Bhasin et al. 2001).
For example, treating adult female laboratory animals
(Exner et al. 1973a; Salmons, 1992), hypogonadal men
(Bhasin et al. 1997), elderlymenwith lowTconcentrations
(Ferrando et al. 2002), and men suffering from AIDS
(Bhasin et al. 2000) with T or any of its many derivatives
(commonly referred to as anabolic–androgenic steroids;
AASs) for several weeks has been shown to increase lean
body mass. Although the mechanisms underlying the
changes in lean body mass are still poorly understood,
it is generally believed that AAS administration increases
protein synthesis (Kochakian, 1950; Ferrando et al. 2002)
while at the same timedecreasing its breakdown (Ferrando
et al. 2002).
Skeletalmuscle has the largest pool of amino acids in the
body with the branched chain amino acids leucine, iso-
luecine and valine forming 35% of total skeletal muscle
proteins (Harper et al. 1984). Therefore, for skeletal
muscle mass to increase, as occurs following the chronic
administration of AASs, it must have an adequate supply
of essential amino acids. However, the few studies that
have investigated amino acid uptake in human skeletal
muscles, following AAS administration, were unable to
demonstrate any changes in their uptake (Ferrando et al.
2002), thereby leaving the source of the new/extra amino
acids unresolved. Therefore, it is still uncertain whether
DHT and T have any effects on amino acid uptake in adult
mammalian skeletal muscle fibres.
Amino acids enter and leave cells through specialized
proteins known as amino acid transporters (Christensen,
1990). Although all cells express a variety of these trans-
porters, the combinations found in each cell type seem
to depend on the physiological functions of the cell and
the location of the transporters, suggesting that their
(the transporters) expression and activity is carefully
regulated (McGivan&Pastor-Anglada, 1994;Wagner et al.
2001). While some of the physiological factors regulating
the activity and expression of amino acid transporters
belonging to system A in mammalian cells have been the
subject of a number of previous studies (Sugawara et al.
2000; Hyde et al. 2002; Franchi-Gazzola et al. 2004; Palii
et al. 2004; Kashiwagi et al. 2009), little is known about
the physiological factors regulating the expression and
activity of L-type amino acid transporters, especially in
adult mammalian skeletal muscle fibres.
Therefore, the primary aims of this study were
to investigate the acute effects of DHT and T on
(1) amino acid uptake, (2) the expression of the amino
acid transporters SNAT2 and LAT2, and (3) the cellular
signalling pathway(s) mediating these actions in fast-
and slow-twitch muscle fibre bundles isolated from
adult female mice. Our results show that DHT, but
not T, increases the uptake of essential amino acids
and their incorporation into proteins in the fast-twitch
skeletal muscle fibre bundles. These effects are mediated
through the EGFR and involved activation of the MAPK
pathway and an increase in the expression of LAT2.
From these results we suggest that another physiological
function of the non-genomic actions of DHT in adult
mammalian skeletal muscle fibres is to regulate the trans-
port of essential amino acids and their incorporation into
proteins.
Methods
Preparation of the small intact skeletal muscle fibre
bundles
All the experiments reported in this study were performed
at room temperature (∼20◦C) on small skeletal muscle
fibre bundles isolated from either the extensor digitorum
longus (EDL, a mainly fast-twitch muscle in adult mice)
or the soleus (a predominantly slow-twitch muscle in
adult mice) of adult female CD1 mice aged 57.4± 2.3
days (n= 34; range 45–79 days). The mice were killed by
cervical disarticulation as recommended by the Animals
(Scientific Procedures) Act 1986, UK (for a summary
of the regulations see Drummond, 2009) and all the
experiments conformed to the local animal welfare
committee guidelines. The EDL and soleus muscles from
both hindlimbs were then isolated and small muscle
fibre bundles, containing approximately 10–15 fibres
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(mean cross-sectional diameter 350± 17μm, n= 68),
were dissected and care was taken to ensure that all
the fibres in a bundle were intact and electrically
excitable.
During an experiment, the muscle fibre bundles were
mounted horizontally between two stainless steel hooks
in specially designed muscle chambers. Two types of
muscle chambers, one with a total volume of 5 ml
and the other 25ml, were used for the determination
of amino acid uptake and cellular-signal transduction
events, respectively. The fibre bundles were continuously
perfused with the standard mammalian Ringer solution
alone or the standard Ringer solution plus the various
compounds/inhibitors listed in Table 1. The composition
of the Ringer solution was (in mM): 109 NaCl, 5 KCl,
1 MgCl2, 4 CaCl2, 24 NaHCO3, 1 NaHPO4, 10 sodium
pyruvate plus 200mg l−1 bovine calf serum; and its pH
was maintained at 7.42 by constantly bubbling it with
95% O2 and 5% CO2.
Determination of the effects of dihydrotestosterone
(DHT) and testosterone (T) on the uptake of
isoleucine and α-(methylamino)isobutyric acid
To determine the uptake of the amino acids,
eight fast-twitch and eight slow-twitch muscle fibre
bundles were divided into two groups. Half were
treated with the standard Ringer solution containing
6.3μl/100ml (107.9μM) ethanol (the vehicle used
to dissolve both DHT and T) plus either 2 mM
[14C]isoleucine (L-[U-14C]Ile; radioactivity level 3.46μCi
ml−1) or 68.3μM α-[14C]methylaminoisobutyric acid
(α-[1-14C]-MeAIB; 2-(methylamino)-2-methylpropionic
acid; radioactivity level 0.8μCi ml −1) (both purchased
from PerkinElmer, Beaconsfield, UK) for 1 h. These
preparations acted as controls. The other half
were treated with the Ringer solution containing
630 pg l−1 4,5α-dihydrotestosterone (2.17 nM; DHT;
5α-androstan-17β-ol-3-one) or testosterone propi-
onate (1.83 nM; T; 17β-hydroxy-4-androsten-3-one 17-
propionate) (both from Sigma-Aldrich, Gillingham,
UK) plus the radio-labelled amino acids for the
same duration (1 h). These fibre bundles acted as the
experimental/treatment group. Radiolabelled Ile was used
in these studies because, unlike leucine, it does not
stimulate protein synthesis in adult mammalian skeletal
muscle (Anthony et al. 2000).
At the end of the experiments described above, the
Ringer solution was aspirated and the fibre bundles were
washed twice in ice-cold phosphate-buffered saline (PBS).
The excess buffer was blotted out and the bundles were
then snap frozen in liquid nitrogen and pulverised, and
cytosolic proteins were extracted using the non-ionic cell
lysis buffer NP40 as described in Mutungi (2008). The
amount of proteins in each lysate was then determined
using the quick Bradford assay (Bradford, 1976). The
rest of the lysate was mixed with an equal amount of
Optima Gold XR liquid scintillant (PerkinElmer) and
the level of radioactivity in the mixture was determined
using a liquid scintillation counter (Tri-Carb 2250 CA,
Canberra-Packard) 1 h and 24 h after the end of each
experiment. Also, each experiment was repeated at least
twice. As T had no effect on amino acid uptake in either
fibre type, the rest of the experiments were performed
using DHT.
To investigate the cellular-signal transduction events
underlying the effects of DHT on amino acid uptake,
the experiments described above were repeated using
eight fast- and eight slow- twitch muscle fibres bundles.
Briefly, half of the fibre bundles were treated with the
standard Ringer solution containing 107.9μM ethanol
plus the radio-labelled amino acids for 1 h. The other
half were pre-incubated for 20min in the standard Ringer
solution containing one of the inhibitors listed in Table 1.
They were then treated, for 1 h, with the Ringer solution
containing DHT plus either 2 mM L-[U-14C]Ile or 68.3μM
α-[1-14C]-MeAIB plus the inhibitor whose effects were
being investigated. Most of the inhibitors used and their
concentrations are similar to those used previously in
Hamdi & Mutungi (2010). The uptake of the amino
acids in the presence and absence of the inhibitors
as well as DHT were then determined as described
above.
In adult mammals, muscle hypertrophy and hence
protein synthesis is regulated by the Akt/mTOR pathway
(Glass, 2003). Therefore, in another experiment we
determined whether the Akt/mTOR pathway affected the
basal uptake of amino acids or the DHT-induced increase
in amino acid transport into the muscle fibre bundles.
Briefly, 16muscle fibre bundles (8 fast- and 8 slow-twitch)
were divided into four groups each consisting of two
fast- and two slow-twitch muscle fibre bundles. Each
group was then treated for at least 20min as follows:
Group 1 (control) was treated with the standard Ringer
solution plus 107.9μM ethanol; Group 2 was treated
with the Ringer solution plus DHT alone; Group 3 was
treated with Ringer solution containing 10 nM deguelin (a
specific (PI3K)/protein kinase B (Akt) inhibitor) (Chun
et al. 2003) or 100 ng ml−1 rapamycin (an mTOR specific
inhibitor) (Shepherd et al. 1995) plus 1 mM ethanol; and
Group 4 was treated with the Ringer solution containing
DHT plus the above concentrations of deguelin and
rapamycin. At the end of this period, the solutions
were replaced with the same solutions but this time
containing 2mM L-[U-14C]Ile. The fibre bundles were
then incubated in these solutions for 1 h after which
the uptake of L-[U-14C]Ile was determined as described
above.
C© 2011 The Authors. Journal compilation C© 2011 The Physiological Society
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Table 1. The proteins/receptors whose effect was being investigated and the inhibitors used
Inhibitors
Protein/process Scientific name Common name Concentration Source
Transcription Actinomycin IV Actinomycin D 1 μg ml−1 Sigma-Aldrich
3-[2-(3,5-Dimethyl-2-oxocyclohexyl)- Cycloheximide 10 μg ml−1 Sigma-Aldrich
Translation 2-hydroxyethyl]glutarimide
LAT2 2-Aminobicyclo[2,2,1] BCH 100 μM Sigma-Aldrich
heptane-2-carboxylic acid
Androgen receptor 6-Chloro-1β,2β-dihydro- Cyproterone 1 μM Sigma-Aldrich
17-hydroxy-3′H-cyclopropa
(1,2)-pregna-1,4,6-triene-3,
20-dione acetate
2-Methyl-N-(4-nitro-3
[trifluoromethyl]
Flutamide 3 μM Sigma-Aldrich
phenyl)propanamide
SNAT2 2-N-Dimethylalanine-2- MeAIB 10 μM Sigma-Aldrich
(methylamino)-2-methylpropionic
acid
EGFR N-[3-Chlorophenyl]-6, AG 1478 100 nM Sigma-Aldrich
7,-dimethoxy-4-quinazolamine
MEK 2′-Amino-3′-methoxyflavone PD98059 20 μM Alexis Biochemicals
Akt (7aS,13aS)-13, Deguelin 10 nM Sigma-Aldrich
13a-Dihydro-9,10-dimethoxy-3,
3-dimethyl-3H-bis[1]benzopyrano
[3,4-b:6′,5′-e]pyran-7(7aH)-one
mTOR 23,27-Epoxy-3H-pyrido[2,1-c] Rapamycin 100 ng ml −1 Sigma-Aldrich
[1,4]oxaazacyclohentriacontine
Determination of amino acid incorporation into
proteins
In another experiment, a modification of the
trichloroacetic acid (TCA) precipitation method was
used (Jiang et al. 2003). Briefly, six fast-twitch and six
slow-twitch fibre bundles were divided into two equal
groups. Half (controls) were treated with the standard
Ringer solution containing 107.9μM ethanol plus 2 mM
L-[U-14C]Ile for 1 h. These preparations acted as controls.
The other half (experimental) were treated with the
Ringer solution containing 630 pgml−1 DHT plus the
radio-labelled amino acid for the same duration (1 h).
At the end of the experiment, proteins were extracted as
described above. The lysates were then mixed with equal
amounts of 10% ice-cold TCA and left standing on ice for
2–3 h. The lysate–TCA mixture was then centrifuged at
15,000 g for 20min and the supernatant was discarded.
The pellet was washed twice in ice-cold acetone and
centrifuged at 15,000 g for 10min, and the supernatant
was discarded. Finally, the pellet was dried, pulverised
and re-dissolved in 50–100μl urea buffer depending on
the size of the pellet. The buffer contained 7 M urea, 2 M
thiourea and 20mM trisbase, pH 8.5. The radioactivity of
the mixture was then determined as described above.
Determination of the amino acid transporter
mediating the effects of DHT on amino acid transport
in mammalian skeletal muscle fibre bundles
Both MeAIB and Ile are neutral amino acids and
are transported across the cell membrane through
system A and system L amino acid transporters,
respectively (Christensen, 1990; Palacin et al. 1998).
Although each of these systems has several isoforms
(Palacin et al. 1998; Mackenzie & Erickson, 2004),
only the sodium-coupled neutral amino acid trans-
porter (SNAT) 2 (Utsunomiya-Tate et al. 1996; Yao
et al. 2000; Hyde et al. 2001; Mackenzie & Erickson,
2004) and the sodium-independent L-type amino acid
transporter (LAT) 2 (Pineda et al. 1999; Segawa
et al. 1999; Sugawara et al. 2000) have consistently
been identified in skeletal muscle. Furthermore, both
these transporters can be inhibited by the synthetic
amino acid analogues α-(methylamino)isobutyric acid
(MeAiB; 2-(methylamino)-2-methylpropionic acid) and
2-aminobicyclo-(2,2,1)heptane-2-carboxylic acid (BCH),
respectively (Christensen, 1985). Therefore, in another
experiment we used these analogues to investigate the
amino acid transporters mediating the effects of DHT on
amino acid uptake observed in the preceding experiments.
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Briefly, the muscle fibre bundles were divided into four
groups each containing four fast- and four slow-twitch
fibre bundles. Each group was then treated for at least
20min as follows: Group 1 (control) was treated with the
standard Ringer solution plus 107.9μM ethanol; Group 2
was treated with the Ringer solution plus DHT alone;
Group 3 was treated with the Ringer solution containing
either BCH or MeAIB alone plus 107.9μM ethanol; and
Group 4 was treated with the Ringer solution containing
DHT plus either 10mM BCH or 100μM MeAIB. At the
end of this period, the solutions were then replaced with
the same solutions but this time 2mM L-[U-14C] Ile was
added. The bundles were then incubated in these solutions
for 1 h after which the uptake of Ile by the fibre bundles
was determined as described above.
BCH inhibits both LAT1 and LAT2. Therefore,
in another experiment we determined whether the
DHT-induced uptake of Ile was through LAT2. Briefly,
another set of fibre bundles (6 fast- and 6 slow-twitch)
was treated for 20min with Ringer solution containing
1:500 dilution of a rabbit polyclonal antibody against
LAT2 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA). They were then incubated for 1 h in the Ringer
solution containing 2mM L-[U-14C]Ile plus either the
antibody alone or the antibody plus DHT. The uptake
of Ile by the fibres was then determined as described
above.
In another experiment, we examined whether DHT
treatment affects the expression of LAT2 and SNAT2 in
the fibre bundles. To do this, we treated another set of
fibre bundles with the standard Ringer solution plus the
vehicle (107.9μMethanol) or the standardRinger solution
plus DHT. Cytosolic and crude membrane proteins were
then extracted and immunoblotted for the expression of
SNAT2andLAT2 (SantaCruzBiotechnology) as described
below.
Determination of the cellular signal transduction
pathway(s) mediating the effects of DHT on amino
acid uptake
To investigate the cellular signal transduction events
mediating the effects of DHT on amino acid uptake,
another set of fibre bundles was treated with the standard
Ringer solution plus the vehicle or the standard Ringer
solution plusDHT for 1 h. In some of the experiments, the
fibre bundles were pre-incubatedwith the standardRinger
solution plus the EGFR inhibitor tyrphostin AG1478 or
the MEK inhibitor PD98059 for 20min. They were then
treated with the Ringer solution containing the inhibitor
whose effects were being investigated plus DHT for 1 h. At
the end of the experiments, proteins were extracted from
themuscle fibre bundles and immunoblotted as described
below.
Immunoblotting
At the end of the experiments described above, the
fibre bundles were snap frozen in liquid nitrogen and
pulverized. Cytosolic and crude membrane proteins were
extracted usingNP40 lysis buffer. To extract cytosolic/total
cell proteins, the lysates were centrifuged for 10min at
15,000 g . The supernatant was then collected and stored
at –80◦C until required. To extract crude membrane
proteins, the pellets from the cytosolic extractions were
washed twice in ice cold PBS and blotted with filter
paper to remove excess PBS. They were then snap frozen
in liquid nitrogen and pulverized, and proteins were
extracted as described above. Equal amounts (10μg) of
the proteins were then immunoblotted as described in
Mutungi (2008). Briefly, the proteins were resolved in
either 10% or 5% SDS-polyacrylamide gels, depending
on the molecular weight of the proteins being probed.
They were then transferred onto PVDF membranes.
The membranes were blocked for non-specific anti-
body labelling with 5% milk for 30min. They were
then incubated overnight at 4◦C with primary anti-
bodies against pEGFR, pJNK, pp38 and pATF2 (from
Cell Signaling Technology, Inc., Danvers, MA, USA);
pEK1/2, cmyc, pcJUN, MyoD, SNAT2 and LAT2 (from
Santa Cruz Biotechnology); and pRSK1/2, pMSK1/2 and
peEF2 (Abcam, Cambridge, UK). The following day
they were washed and incubated for 2 h with species
specific secondary antibodies conjugatedwith horseradish
peroxidase. Finally, they were visualised using SuperSignal
WestPico (Perbio Science UK Ltd, Cramlington, UK)
chemiluminescence substrate and exposure to film.
The following day, the membranes were stripped
as described in Hamdi & Mutungi (2010). They
were then re-probed with either a pan-actin antibody
(ab3280) from Abcam or an antibody against the total
(unphosphorylated) protein whose phosphorylation was
being investigated. These blots were used as loading
controls. In some experiments, the fibre bundles were also
fibre typed using monoclonal antibodies against fast and
slow MyHCs (Sigma-Aldrich).
Analysis and data handling
The radioactivity of each lysate was counted and expressed
as the disintegration perminute. It was then normalized to
the protein content of the lysate and expressed as becquerel
permicrogramofprotein (Bqμg−1).The radioactivitywas
thennormalized to that recordedunder control conditions
and all the data are presented as the mean percentage
change in uptake± SD.
All the Western blots were run in triplicate and each
experiment was repeated at least three times. To determine
the statistical significance of the changes, the intensity
of the bands, from each experiment, was analysed using
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ImageJ (Scion/NIH) and was normalized to that of the
loading control (either actin or the total protein).
Statistical analysis of the data was performed using
SigmaPlot 11.2 (Systat Software Inc., San Jose, CA, USA).
The data obtained from the two fibre types under control
and from the various experimental conditions were then
compared using a three-way ANOVA and P < 0.05 was
considered statistically significant.
Results
Acute effects of DHT and T on amino acid uptake in
fast- and slow-twitch skeletal muscle fibre bundles
Treatment of the fibre bundles with physiological
concentrations (630 pgml−1) of DHT significantly
(P = 0.001) increased the uptake of L-[U-14C]Ile and
α-[1-14C]MeAIB in the fast-twitch fibre bundles without
significantly (P = 0.72) affecting that of the slow-twitch
ones. For example, DHT led to an 88.7± 14% (n= 4
fibre bundles) increase in the uptake of L-[U-14C]Ile in
the fast-twitch fibre bundles but only to a 5.9± 4.5%
(n= 4 fibre bundle) increase in the slow-twitch ones
(Fig. 1A). The corresponding values for α-[1-14C]MeAIB
were 53.9± 12.8% (n= 4 fibres) and 7.0± 4.0% in the
fast- and slow-twitch fibre bundles, respectively (Fig. 1B).
In contrast, T did not significantly (P = 0.47 and 0.59
for Ile and MeAIB, respectively) affect the uptake of
L-[U-14C]Ile and α-[1-14C]MeAIB in either fibre type
(Fig. 1C andD). For example, it led to a 3.2± 4.9% (n= 4
fibres) increase and to a 4.4± 5% (n= 4 fibres) decrease
in the uptake of L-[U-14C]Ile in the fast- and slow-twitch
muscle fibres, respectively (Fig. 1C). The corresponding
values for α-[1-14C]MeAIB) were 6.0± 5% (n= 4 fibres)
increase and 6.5± 5% (n= 4 fibres) decrease in the fast-
and slow-twitch fibres, respectively (Fig. 1D).
Amino acid transporter(s) mediating the effects of
DHT on amino acid transport in isolated intact
mammalian skeletal muscle fibre bundles
Figure 2 shows the effects of pre-incubating another
set of fast- and slow-twitch muscle fibre bundles with
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Figure 1. DHT but not T increases amino acid uptake in fast-twitch skeletal muscle fibre bundles
Bar graphs showing the effects of treating fast- (filled bars) and slow- (open bars) twitch fibre bundles with
physiological levels of DHT (A and B) and T (C and D) on the uptake of L-[U-14C]Ile (A and C) and α-[1-14C]MeAIB
(B and D). Note that treating the fibre bundles with DHT, but not T, significantly (P = 0.001) increases the uptake
of both L-[U-14C]Ile and α-[1-14C]MeAIB) in the fast-twitch fibre bundles. In contrast, DHT had little effect on the
uptake of both amino acids in the slow-twitch bundles. ∗P < 0.05 when compared to control.
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100μM MeAiB (a system A inhibitor) on the basal
and DHT-induced uptake of L-[U-14C]Ile. As the results
show, treatment of the muscle fibre bundles with
DHT significantly (P < 0.001) increased the uptake of
L-[U-14C]Ile in the fast-twitch fibre bundles only. In
contrast, pre-incubating the fibre bundles with MeAIB
significantly (P < 0.05) decreased the basal uptake of
L-[U-14C]Ile in both fibre types (Fig. 2A). Also, it
completely abolished the DHT-induced increase in Ile
uptake in both fibre types (Fig. 2A), suggesting that
a system A amino acid transporter was probably
involved. However, as the results displayed in Fig. 2B
show, treatment of the muscle fibres with DHT did
not significantly (P > 0.05) affect the expression of
SNAT2 (the commonest system A amino acid transporter
identified in skeletal muscle) in both fibre types.
In another experiment, we investigated the effects of
pre-treating the muscle fibre bundles with the L-type
amino acid transporter inhibitor, BCH. Treatment of the
muscle bundles with BCH alone significantly (P < 0.05)
decreased the basal transport of L-[U-14C]Ile in both fibre
types. Also, it completely abolished the DHT-induced
increase in L-[U-14C]Ile uptake (Fig. 3A), suggesting that
the increase was via an L-type amino acid transporter.
However, from these experiments itwasuncertainwhether
the transporter was LAT1 or LAT2. Therefore, in another
experiment we examined the effects of DHT on the
expression of LAT2. In the untreated fibre bundles, the
slow-twitch muscle fibre bundles always expressed higher
concentrations of the transporter than the fast-twitch
ones. Moreover, treating the fibre bundles with DHT
significantly (P = 0.01) increased the expression of LAT2
in the fast-twitch fibre bundles without significantly
(P = 0.13) affecting its expression in the slow-twitch
ones. LAT2 was extracted mainly in the membrane
fraction of the fibres, whereas, SNAT2 was extracted
mainly in the cytosolic fraction. Again these results
suggest that the effects of DHT were probably mediated
through LAT2. However, they were not conclusive.
Therefore, in another experiment, we used an antibody
against LAT2 as an inhibitor of the transporter. As the
results displayed in Fig. 3C show, treatment of the fibre
bundles with the antibody alone significantly (P < 0.05)
reduced the basal transport of L-[U-14C]Ile in both fibre
types. Also, it completely abolished the DHT induced
uptake of L-[U-14C]Ile (Fig. 3C) in the fast-twitch fibre
bundles.
Receptor(s) mediating the effects of DHT on amino
acid transport in isolated intact mammalian skeletal
muscle fibre bundles
DHT and T have both genomic and non-genomic
actions (Heinlein & Chang, 2002; Hamdi & Mutungi,
2010). The genomic actions are mediated through
Figure 2. The effects of DHT on amino acid uptake in mouse skeletal muscle fibre bundles are partly
mediated through a system A amino acid transporter
A, bar graphs showing the effects of treating fast-twitch (filled bars) and slow-twitch (open bars) muscle fibre
bundles with DHT and MeAIB, as shown, on the uptake of L-[U-14C]Ile. B, a representative Western blot and
summary data showing the effects of DHT on the expression of SNAT2 in cytosolic proteins extracted from fast-
(F, filled bars) and slow- (S, open bars) twitch muscle fibre bundles. Note that treating the muscle fibre bundles
with MeAIB significantly (P < 0.05) reduces the basal as well as the DHT-induced increase in Ile uptake in both
fibre types. Furthermore the antibody labels a single band with a molecular mass of ∼60 kDa and DHT treatment
has no effect on the expression of SNAT2. FT and ST are the fast- and slow-twitch preparations treated with DHT,
respectively. ∗P < 0.05 compared to control; †P < 0.05 compared to DHT treatment.
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the classical androgen receptors (Fuller, 1991), whereas
the non-genomic ones are mediated through surface
membrane receptors such as the epidermal growth
factor receptor (EGFR; Hamdi & Mutungi, 2010) and
an unidentified G-protein coupled androgen receptor
(GPCR; Estrada et al. 2003). Therefore, in another
experiment we determined whether the effects of DHT
on amino acid transport reported above were mediated
through the androgen receptor. As the results displayed
in Fig. 4 show, treatment of the fibre bundles with
cyproterone (Fig. 4A; a steroidal inhibitor of the AR)
alone significantly (P < 0.05) increased the basal uptake
of L-[U-14C]Ile in both fibre types. On the other
hand, it significantly (P < 0.05) reversed the effects
of DHT on amino acid uptake in both fibre types.
Thus, pre-treating the fibre bundles with cyproterone
significantly (P = 0.001) reduced the DHT-induced
increase in amino acid uptake in the fast-twitch fibre
bundles, whereas in the slow-twitch ones it led to a further
(12.4± 4%) increase in the uptake of L-[U-14C]Ile. In
contrast, treatment of the fibre bundles with flutamide
(Fig. 3B; a non-steroidal AR inhibitor) alone significantly
(P = 0.007) increased the basal uptake of L-[U-14C]Ile in
the fast-twitch fibre bundles only, whereas pre-treating
Figure 3. The effects of DHT on amino acid uptake in mouse skeletal muscle fibre bundles are mediated
through LAT2
A, bar graphs showing the effects of treating fast- (filled bars) and slow- (open bars) twitch muscle fibre bundles
with DHT and BCH, as shown, on the uptake of L-[U-14C]Ile. B, a typical Western blot and summary data showing
the effects of DHT on the expression of LAT2 in membrane proteins extracted from fast- (F, filled bars) and slow-
(S, open bars) twitch fibre bundles. Note that treating the muscle fibre bundles with BCH significantly (P < 0.05)
reduces the basal as well as the DHT-induced increase in Ile uptake in both fibre types. Additionally, the antibody
labels a single band with a molecular mass of ∼60 kDa and that DHT treatment increases the expression of LAT2
in the fast-twitch fibres only. FT and ST are the fast- and slow-twitch preparations treated with DHT, respectively.
∗P < 0.05 compared to control; †P < 0.05 compared to DHT treatment.
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Figure 4. The effects of DHT on amino acid uptake in mouse skeletal muscle fibre bundles are partly
mediated through the androgen receptor
Bar graphs showing the effects of treating fast- (filled bars) and slow- (clear bars) twitch skeletal muscle fibre
bundles with the standard Ringer solution or the Ringer solution plus physiological levels of DHT alone or DHT plus
the androgen receptor inhibitors cyproterone (A) and flutamide (B). Note that treatment of the fibre bundles with
cyproterone alone significantly (P = 0.001 and 0.005 in the fast- and slow-twitch fibres, respectively) increases
the basal uptake of L-[U-14C]Ile in both fibre types. In contrast, flutamide on its own significantly (P = 0.028)
increases amino acid uptake in the fast-twitch fibre bundles only. Additionally, pre-treating the fibre bundles with
both compounds significantly (P < 0.05) reduces the DHT-induced increase in Ile uptake. However, these effects
were greater in the fibre bundles pre-treated with flutamide than in those pre-treated with cyproterone. ∗P < 0.05
compared to control; †P < 0.05 compared to DHT treatment.
the fibre bundles with it completely reversed the
DHT-induced amino acid uptake seen in the fast-twitch
fibre bundles.
Previously, we have shown that the acute/non-genomic
effects of DHT on force production in isolated intact
mammalian skeletal muscle fibre bundles are mediated
through the epidermal growth factor receptor (EGFR)
(Hamdi & Mutungi, 2010). Therefore, in another
experiment we investigated whether this receptor (EGFR)
mediated the acute/non-genomic effects ofDHTonamino
acid uptake in these fibre bundles. As the results displayed
in Fig. 5A show, treatment of the fibre bundles with the
EGFR inhibitor AG1478 alone significantly (P < 0.05)
decreased the basal uptake of L-[U-14C]Ile in both fibre
types. Also, it completely abolished the DHT-induced
increase in amino acid uptake in the fast-twitch muscle
fibre bundles (Fig. 5A).
Upon stimulation, the EGFR dimerises and then under-
goes autophosphorylation (Mendelsohn&Baselga, 2000).
Therefore, in another experiment we examined the effects
Figure 5. The effects of DHT on amino acid uptake in mouse skeletal muscle fibre bundles are mediated
through the epidermal growth factor receptor (EGFR)
A, bar graphs showing the effects of treating fast- (filled bars) and slow- (clear bars) twitch muscle fibre bundles
with either DHT or tyrphostin AG1478 as shown in the figure. Note that treating the fibre bundles with AG1478
significantly (P < 0.05) reduces the basal uptake of (L-[U-14C] Ile) in both fibre types. Also, it completely abolishes
the DHT-induced increase in amino acid uptake in the fast-twitch muscle fibre bundles. B, a Western blot showing
the effects of treating the muscle fibre bundles with DHT alone or DHT plus AG1478 on the phosporylation of the
EGFR in membrane proteins. Note that the antibody labels a single band with a molecular mass of ∼170 kDa and
that treating the bundles with DHT increases the phosphorylation of EGFR and this effect is completely reversed
by AG1478. ∗P < 0.05 compared to control; †P < 0.05 compared to DHT treatment.
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ofDHTon thephosphorylationof theEGFR.As the results
displayed in Fig. 4B show, treatment of the fibre bundles
withDHT led to amarked increase in the phosphorylation
of the EGFR in the fast-twitch fibre bundles. Furthermore,
this DHT-induced increase in the phosphorylation of
the EGFR was completely abolished by pre-treating the
fibre bundles with Ringer solution containing the EGFR
inhibitor tyrphostin AG1478.
The cellular signal transduction events mediating the
effects of DHT on amino acid transport in isolated
intact mammalian skeletal muscle fibre bundles
To determine the cellular-signal transduction events
mediating the acute/non-genomic actions of DHT on
amino acid uptake in these muscles, another set of
fibre bundles was treated with DHT alone or DHT
plus the mitogen-activated protein kinase kinase (MEK)
inhibitor, PD98059. The uptake of L-[U-14C]Ile as well as
the phosphorylation of the extracellular-signal regulated
kinases (ERK)1/2, the 90 kDa ribosomal S6kinases
(RSK)1/2 and the mitogen and stress-activated protein
kinases (MSK)1/2 were then determined. Treatment of
the muscle fibre bundles with DHT increased the uptake
of L-[U-14C]Ile in the fast-twitch fibre bundles (Fig. 6A).
On the other hand, treating them with PD98059 alone
significantly decreased the basal uptake of L-[U-14C]Ile
in both fibre types. Also, PD98059 completely abolished
the DHT-induced increase in amino acid uptake in the
fast-twitch fibre bundles (Fig. 6A).
When the phosphorylation of ERK1/2 was examined,
we found that the untreated fibre bundles expressed
mostly phosphorylated ERK 2 (p42). Furthermore, its
expression was always greater in the fast than in the
slow-twitch fibre bundles. Moreover, phosphorylated
ERK 1 (p44) was observed mainly in the fibre bundles
treated with DHT. In contrast, the untreated fast- and
slow-twitch fibres expressed similar concentrations of
pRSK1/2 and treatment of the fibre bundles with DHT
significantly (P = 0.03) increased its phosphorylation in
both fibre types (Fig. 6B). In Fig. 6C, the effects of
pre-treating the fibre bundles with PD98059 on the
phosphorylation of ERK1/2 and RSK1/2 are shown. As the
results show, pre-treating the fibre bundles with PD98059
completely abolished the DHT-induced increase in the
phosphorylation of both ERK1/2 and RSK1/2 in the two
fibre types (Fig. 6C). Unlike, ERK and RSK, the untreated
fibre bundles expressed mainly phosphorylated MSK
and its phosphorylation was not significantly (P > 0.05)
affected by treatment with DHT except in the slow-twitch
fibre bundles where it was slightly reduced (Fig. 6B).
The results reported in the previous section clearly
showed that DHT was exerting its effects on amino
acid uptake through activation of the ERK1/2 module of
the MAPK pathway. Its effects on the activation of the
other modules have never been investigated. Therefore,
in another experiment we determined the effects of DHT
on the activation of c-Jun N-terminal kinase (JNK) and
p38 (stress-activated protein kinase, SAPK). As the results
displayed in Fig. 6D show, under control conditions the
slow-twitch fibre bundles always expressed higher levels
of the phosphorylated proteins than the fast-twitch ones.
Additionally, treating the fibre bundles with DHT did not
significantly (P = 0.08) affect the phosphorylation of both
kinases in either fibre type (Fig. 6D).
Another cell signallingpathway that has been implicated
in the regulation of skeletal muscle mass (Glass, 2003)
and hence amino acid uptake (Beugnet et al. 2003; Avruch
et al. 2009) is theAkt (protein kinase B)/mammalian target
of rapamycin (mTOR) pathway. Therefore, in another
experiment we investigated the role of this pathway on
the DHT-induced increase in amino-acid uptake. As the
results in Fig. 7 show, treatment of themuscle fibre bundles
with deguelin and rapamycin decreased the basal uptake
of L-[U-14C]Ile in both muscle fibre types, suggesting that
this pathway plays an essential role in the maintenance
of basal amino acid transport in mammalian skeletal
muscle fibres. Additionally, pre-treating the fibre bundles
with rapamycin completely abolished the DHT-induced
changes in amino acid uptake seen in the fast-twitch
muscle fibres (Fig. 7B). In contrast, pre-treating the
fibre bundles with deguelin blunted, without completely
abolishing, the DHT-induced increase in L-[U-14C]Ile
uptake in the fast-twitch muscle fibre bundles (Fig. 7A).
DHT increases protein synthesis in isolated intact
mammalian skeletal muscle fibre bundles
To determine whether the effects of DHT on amino acid
uptake involved an increase in transcriptionor translation,
another set of fibre bundles was treated with either the
transcriptional inhibitor actinomycin D or translational
inhibitor cycloheximide. The uptake of L-[U-14C]Ile was
then examined in the presence or absence of DHT.
As the results in Fig. 8 show, treatment of the fibre
bundles with actinomycin D alone did not significantly
(P = 0.47 in the fast-twitch and 0.13 in the slow-twitch
fibre bundles) affect the basal uptake of L-[U-14C]Ile in
either fibre type. However, pre-treatment of the fibre
bundles with it significantly (P = 0.001) reduced the
DHT-induced increase in L-[U-14C]Ile uptake without
completely abolishing it (Fig. 8A). In contrast, treatment
of the fibre bundles with cyclohexamide significantly
(P < 0.05) reduced thebasal uptakeof L-[U-14C]Ile inboth
fibre types and pre-treating another set of fibre bundles
with it completely abolished the DHT-induced increase
in L-[U-14C]Ile observed in the fast-twitch fibre bundles
(Fig. 9A).
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Upon activation, MAPKs can translocate into the
nucleus where they regulate gene expression by phospho-
rylating many transcription factors including C-jun,
c-myc and ATF (Krishna & Narag, 2008). Therefore, in
another experiment, we examined the effects of DHT on
some of these transcription factors as well as the trans-
lational regulator, eukaryotic elongation factor (eEF) 2. As
the results displayed in Fig. 8B show, treating the muscle
fibre bundles with DHT had little or no effect on the
expression and activation of cmyc, MyoD and c- Jun.
On the other hand, it increased the phosphorylation of
ATF2 (Fig. 8B) and completely abolished that of eEF2 in
both fibre types (Fig. 9B). Furthermore, treatment of the
muscle fibre bundles with DHT significantly (P < 0.05)
increased the incorporation of Ile into proteins in the
fast-twitch fibre bundles. In contrast, it led to a slight
Figure 6. The effects of DHT on amino acid uptake in mouse skeletal muscle fibre bundles are mediated
through the ERK pathway
A, bar graphs showing the effects of treating fast- (filled bars) and slow- (open bars) twitch muscle fibre bundles
with either DHT or the MEK inhibitor PD98059, as shown in the figure, on the uptake of L-[U-14C]Ile. Note
that treating the fibre bundles with PD98059 significantly reduces the basal uptake of Ile in both fibre types.
Also, it completely abolishes the DHT-induced increase in Ile. B, Western blots showing the effects of treating
muscle fibre bundles with DHT on the phosphorylation of ERK1/2, RSK1/2 and MSK1/2. Note that treating the
muscle fibre bundles with DHT increases the phosphorylation of ERK1/2 and RSK1/2 but not that of MSK1/2. C,
Western blots showing the effects of treating small muscle fibre bundles with DHT and PD98059 (as shown) on
the cytosolic concentrations of phosphorylated ERK1/2 and RSK1/2. Note that the pERK antibody labels two bands
with molecular masses of ∼42 and 44 kDa, whereas that of pRSK labels two bands with molecular masses of ∼78
and 80 kDa. Furthermore, treating the bundles with DHT increases the phosphorylation of ERK1/2 and RSK1/2 and
that pre-treatment of the fibre bundles with PD98059 completely abolishes the effects of DHT. D, typical Western
blots showing the effects of DHT on the cytosolic concentrations of phosphorylated JNK and p38. Note that the
pJNK antibody labels a single band with a molecular mass of ∼60 kDa, whereas that of pp38 labels a band with a
molecular mass of ∼42 kDa. Furthermore, DHT treatment has no effect on the phosphorylation of either kinase.
∗P < 0.05 compared to control; †P < 0.05 compared to DHT treatment.
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Figure 7. The effects of DHT on amino acid uptake in mouse skeletal muscle fibre bundles are not
mediated through the Akt
A and B, bar graphs showing the effects of treating fast- (filled bars) and slow- (open bars) twitch muscle fibre
bundles, with the compounds shown below each panel, on the uptake of L-[U-14C]Ile. Note that treating the fibre
bundles with either deguelin or rapamycin alone significantly (P = 0.033 for deguelin and 0.025 for rapamycin)
reduces the basal uptake of L-[U-14C]Ile in both fibre types. Furthermore, rapamycin but not deguelin abolished
the DHT-induced increase in Ile uptake. ∗P < 0.05 compared to control; †P < 0.05 compared to DHT treatment.
Figure 8. Actinomycin D blunts the effects of DHT on amino acid uptake in mouse skeletal muscle fibre
bundles
A, bar graphs showing the effects of treating fast- (filled bars) and slow- (open bars) twitch muscle fibre bundles
with Ringer solution containing either DHT or actinomycin D on the uptake of L-[U-14C]Ile. Note that treating
the muscle fibre bundles with actinomycin D alone had no effect on the basal uptake of Ile in both fibre types.
Moreover, it blunts without completely abolishing the DHT-induced increase in Ile uptake. B, representativeWestern
blots showing the effects of DHT on the expression of pc-Jun, myoD, cmyc and pATF2. Note that DHT does not
significantly (P > 0.05) affect the phosphorylation/expression of any of the transcriptional factors except ATF2.
∗P < 0.05 compared to control; †P < 0.05 compared to DHT treatment.
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(9.8± 5.6%, n= 3 fibres) decrease in Ile incorporation
in the slow-twitch fibre bundles (Fig. 9C), suggesting that
DHT treatment was also regulating protein synthesis in
the fibre bundles.
Discussion
A key finding in the present study was the observation
that treating small skeletal muscle fibre bundles isolated
from the EDL and soleus of adult female mice with
physiological concentrations (630 pgml−1) of DHT, for
1 h, significantly (P = 0.001) increased the uptake of both
Ile and MeAiB in the fibre bundles isolated from the
EDL but not in those isolated from the soleus. Although
the acute administration of hormones such as insulin
(Biolo et al. 1995), insulin-like growth factor 1 (IGF-1)
(Fryburg et al. 1995) and growth hormone (Fryburg
et al. 1995) has been shown to increase protein synthesis
and to promote amino acid uptake in human skeletal
muscle, this is the first time that an increase in amino
acid uptake in response to the acute administration of an
anabolic-androgenic steroid in adult mammalian skeletal
muscle has been demonstrated. Only two other studies
have previously investigated the effects of T on amino acid
uptake. Both studies used human subjects andwere unable
to demonstrate any changes in amino acid uptake inwhole
muscle groups (Bhasin et al. 1997; Ferrando et al. 1998).
Although small skeletal muscle fibre bundles were used in
the present study and T was applied directly to the fibre
bundles, it is important to note that T had no effect on
amino acid uptake in either fibre type. In contrast, treating
the fibre bundles with DHT led to a marked increase in
Figure 9. Actinomycin D blunts the effects of DHT on amino acid uptake in mouse skeletal muscle fibre
bundles
A, bar graphs showing the effects of treating fast- (filled bars) and slow- (open bars) twitch muscle fibre bundles
with Ringer solution containing either DHT or cycloheximide on the uptake of L-[U-14C]Ile. Note that treating
the muscle fibre bundles with cycloheximide significantly (P < 0.05) reduces the basal uptake of Ile in both fibre
types. Moreover, pre-treatment of the fibre bundles with it completely abolishes the DHT-induced increase in Ile
uptake. B, representative Western blots showing the effects of DHT on the phosphorylation of eEF2. Note that
the antibody labels a single band with a molecular mass of ∼100 kDa. Moreover, treatment of the muscle fibre
bundles with DHT completely abolishes the phosphorylation of the protein in both fibre types. C, summary data
showing the effects of treating muscle fibre bundles with DHT on Ile incorporation into the muscle fibre bundles.
Note that treating the muscle fibre bundles with DHT significantly (P = 0.004) increases the incorporation of Ile in
the fast-twitch fibre bundles. In contrast it leads to a slight decrease (9.8 ± 5.6%, n = 3 fibres) in the incorporation
of Ile in the slow-twitch fibre bundles. ∗P < 0.05 compared to control; †P < 0.05 compared to DHT treatment.
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the uptake of both Ile and MeAIB in the fast-twitch fibre
bundles only (Fig. 1). Previously, we have also shown
that T has no acute effects on force production in iso-
lated intact mouse skeletal muscle fibre bundles, whereas
DHT increased force production in the fast-twitch fibre
bundles but decreased it in the slow-twitch ones (Hamdi
& Mutungi, 2010). Taken together, these findings suggest
that T may not have any acute/non-genomic effects in
adult mammalian skeletal muscle fibres.
As mentioned in the introduction, in most tissues
T is converted into DHT by the enzyme 5α-reductase.
Therefore, it is likely that all the acute effects of T observed
previously in cultured myocytes (Estrada et al. 2003) may
have been exerted by DHT. Indeed, it has previously been
suggested that the anabolic effects of T in human skeletal
muscles may be indirect or secondary to the release of
another hormone such as IGF-1 (Ferrando et al. 1998).
Herewe speculate that in addition to IGF-1, the effects of T
inmammalian skeletalmusclemay alsobe exerted through
the release of DHT. We also suggest that DHT is the main
anabolic–androgenic steroid in adult mammalian skeletal
muscles.
Although all the experiments reported here were
performedusingmusclefibrebundles isolated fromfemale
mice, we suggest that these hormones have similar effects
in muscle bundles isolated from male mice. Indeed, we
have previously shown that DHT has similar effects on
forceproduction inmale and femalemouse skeletalmuscle
fibre bundles (Hamdi &Mutungi, 2010). Themain reason
we used femalemuscles in this study was to avoid previous
exposure to these hormones as these may compromise
their effects (see Exner et al. 1973a,b). As mentioned in
the introduction, anabolic–androgenic steroids are major
determinants of body composition and their presence or
absence in plasma has huge effects on body structure
and composition (Wilson et al. 1988; Regnier & Herrera,
1993; Bhasin et al. 2001). Therefore, we speculate that
the presence of these hormones in males may be the
main reason male muscles are larger and stronger than
those of females. Indeed, in frogs the flexor carpi radialis
muscle has been shown to be dimorphic and sensitive to
testosterone (Regnier &Herrera, 1993).However, whether
the differences between the muscles of males and females
are due to these hormones only is uncertain and further
investigation is needed.
Amino acids enter and leave cells through highly
specialized proteins knownas amino acid carriers or trans-
porters. Moreover, each cell expresses numerous varieties
of these transporters (Christensen, 1990). As the data
displayed in Figs 2 and 3 show, in addition to other trans-
porters, adult mouse fast- and slow-twitch skeletal muscle
fibres express both SNAT2 (a system A amino acid trans-
porter) and LAT2 (an amino acid transporter belonging to
system L). Although mRNAs for these transporters have
previously been identified in mammalian skeletal muscle
(Utsunomiya-Tate et al. 1996; Pineda et al. 1999; Segawa
et al. 1999; Sugawara et al. 2000; Yao et al. 2000; Hyde
et al. 2001), this is the first time the protein for LAT2
has been shown to be present in adult mammalian skeletal
muscle. It is also the first time the expression of both trans-
porters in different muscle fibre types has been described.
As the data in Fig. 2 show, the untreated slow-twitch
muscle fibre bundles express more (∼1.8 times) trans-
porter proteins than the corresponding fast-twitch
fibres. However, whether this difference is physio-
logically important is uncertain and further studies are
necessary.
It is now generally accepted that certain nutrients
such as amino acids are essential for the maintenance of
tissue structure, growth and function. Therefore, it has
been suggested that their uptake and release by cells is
highly regulated. Although many factors including pH
(Sugawara et al. 2000; Yao et al. 2000), osmolarity (Horio
et al. 1997), intracellular amino acid levels (Gazzola et al.
1972; Drummond et al. 2010), hormones (Edmondson
& Lumeng, 1980; Barber et al. 1982), growth factors
(Moule&McGivan, 1987) andmitogens (Franchi-Gazzola
et al. 1999) have been shown to regulate the expression
and activity of SNAT2 (so called adaptive response) in
many cell types, far less is known about the factors
that control the activity and function of L-type amino
acid transporters. The results we report in this study
(see Figs 2 and 3) show that although DHT increases
the activity of SNAT2, it does not affect its expression.
Instead, it increases the activity and expression of LAT2
(see Fig. 3). Furthermore, preloading the muscle fibre
bundles with the classical system A and L-type amino acid
inhibitors led to a marked decrease in the basal uptake of
L-[U-14C]Ile in both fibre types and completely abolished
the DHT-induced increase in Ile uptake. Similar effects
were also observed when the fibre bundles were treated
with Ringer solution containing an antibody against LAT2
(see Fig. 3C), suggesting that the effects of DHT on
Ile are mediated through this transporter. From these
observations we suggest that the two transporters (LAT2,
SNAT2) are somehow linked. Thus, by modulating the
expression and activity of LAT2, DHT also seems to
indirectly regulate the activity of SNAT2. This type of
coupling, commonly referred to as tertiary active trans-
port, has been previously reported and is thought to exist
in most cells (Hyde et al. 2007; Baird et al. 2009). Indeed,
recent data published by Drummond et al. (2010) suggest
that it may also exist between SNAT2 and LAT1 in human
skeletal muscle, suggesting that this type of coupling may
be widespread in skeletal muscle. However, further studies
to confirm this are necessary.
Previously, we have shown that the acute/non-genomic
actions of DHT on force production in adult mouse
skeletal muscle fibre bundles are mediated through the
epidermal growth factor receptor (EGFR) and involve
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activation of ERK1/2 (Hamdi & Mutungi, 2010). It
is interesting to note that the results we report here
suggest that the acute/non-genomic actions of DHT on
amino acid uptake in adult mammalian skeletal muscle
fibres are also mediated through the same receptor
and pathway. However, as the data presented in Fig. 4
show, involvement of the classical androgen receptors
in the DHT-mediated increase in amino acid uptake
cannot be ruled out. Thus, pre-treating the fibre bundles
with either cyproterone (Fig. 4A) or flutamide (Fig. 4B)
significantly (P < 0.05) blunted the effects of DHT on
Ile uptake without completely abolishing them. Pre-
viously, it has been suggested that testosterone can activate
the MAPK pathway via a G-protein coupled androgen
receptor (Estrada et al. 2003). However, whether this
mechanism(s), commonly referred to as transactivation,
is the one that mediates the acute/non-genomic effects
of DHT in adult mammalian skeletal muscle fibres
is uncertain and further research to clarify this is
necessary.
Upon activation, ERK1/2 can either remain in the
cytosol or translocate into the nucleus where it plays a
critical role in the regulation of both gene expression and
DNA replication (Brunet et al. 1999). In the nucleus,
ERK1/2 phosphorylates an array of targets, including
many transcription factors and a family of RSK-related
kinases, the mitogen- and stress-activated protein kinases
(MSKs) (Deak et al. 1998). Although a large number of the
downstream targets of ERK1/2 were examined in the pre-
sent study, DHT treatment increased the phosphorylation
of RSK1/2 andATF2 only. Additionally, DHThad no effect
on the phosphorylation of the other MAPK modules.
To us, these findings suggest that the acute/non-genomic
actions of DHT in adult mammalian skeletal muscles are
exerted mainly through the EGFR and involve activation
of the ERK1/2 module of the MAPK pathway (for details
see Fig. 10). Our hypothesis is that DHT, either directly
or indirectly, activates the EGFR which in turn activates
the MAPK pathway leading to an increase in amino acid
transport into the fibres andprotein synthesis by the fibres.
Furthermore, DHT seems to target mainly fast-twitch
fibres.
In adult animals, an increase in skeletal muscle
mass (hypertrophy) occurs mainly as a result of an
increase in the size rather than the number of muscle
fibres and is generally thought to be regulated by
the Akt/mTOR pathway (Glass, 2003). The Akt/mTOR
pathway is activated by many stimuli including growth
factors, hormones and nutrients. Moreover, its activation
culminates in the block of apoptosis, induction of protein
synthesis, gene transcription and cell proliferation (Dann
et al. 2007). Therefore, we expected thatDHT andTwould
activate this pathway. However, as the results displayed in
Fig. 7 show, the AKT specific inhibitor degulin blunted
Figure 10. Cell signalling pathway mediating the effects of DHT on amino acid transport in mammalian
skeletal muscle fibres
A schematic diagram showing the cellular signalling pathway we suggest mediates the acute effects of DHT
on amino acid in mammalian skeletal muscle fibre bundles. Our hypothesis is that DHT, through an unknown
mechanism, activates the EGFR and this leads to the activation of RSK1/2 by ERK1/2. The activated RSK1/2 then
increases the activity and expression of LAT2 (blue circle with a cross), which in turn increases the transport of Ile
into the muscle fibre bundles. Additionally, RSK1/2 enhances the mRNA translation into proteins. Note that the
transport of Ile is coupled to that of small neutral amino acids such as glutamine (Gln) that are transported into the
cell by system A amino acid transporters such as SNAT2 (red circle with a cross). Thus, an increase in the activity of
LAT2 indirectly increases the activity of SNAT2. The eventual effects of all these processes are to increase protein
synthesis and hence skeletal muscle mass especially in fast-twitch muscle fibres.
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the DHT-induced amino acid uptake in fast-twitch fibres
without completely abolishing it, thereby suggesting that
the acute/non-genomic actions of DHT are not mediated
through Akt. Instead, the results we present suggest that
DHT increases protein synthesis by regulating the trans-
lation of mRNA already present in the cells. Indeed,
treatment of the muscle fibre bundles with DHT led
to a marked decrease in the phosphorylation of eEF2
and a moderate (∼50%) increase in protein synthesis
in the fast skeletal muscle fibre bundles (see Fig. 9C).
Furthermore, pre-treating thefibrebundleswith the trans-
lational inhibitor cycloheximide completely abolished
the DHT-induced increase in amino acid uptake. cyclo-
heximide is a glutarimideantibiotic thatbinds theE-siteon
the 60S ribosomal subunit thereby inhibiting the binding
of eEF2 on this site and tRNA translocation from theA-site
to theP-site (Schneider-Petsch et al.2010). Therefore, both
of these observations provide further evidence in support
of ourhypothesis thatDHTincreases aminoaciduptakeby
increasingmRNA translation. However, this cannot be the
only mechanism involved because pre-treating the fibre
bundles with the transcriptional inhibitor actinomycin D
also abolished the DHT-induced increase in amino acid
uptake. However, as DHT did not increase the activity of
many of the transcription factors examined in this study,
we hypothesis that it increases the transcription of genes
that are already active.
It is also noteworthy that pre-treating the fibre bundles
with the mTOR specific inhibitor rapamycin not only
reduced the basal uptake of Ile, it also completely abolished
the DHT-induced increase in the uptake of Ile in the
fast-twitch fibre bundles. To us these findings suggest
that some of the acute/non-genomic effects of DHT are
probably mediated through mTOR. Indeed, a number of
studies have suggested that mTOR is the link between
amino acid availability and increased protein synthesis
(Beugnet et al. 2003; Avruch et al. 2009). However,
rapamycin can also induce autophagy (Ravikumar et al.
2004). Therefore, another possibility is that its effects
are due to a build up of amino acids in the muscle
fibres. However, the exact mechanism underlying the
effects of rapamycin is uncertain and further studies are
necessary.
In summary, the resultswe report in this study show that
another physiological function of the acute/non-genomic
actions of DHT in adult mammalian skeletal muscle
fibres is to increase the uptake of essential amino
acids. Although we cannot completely rule out androgen
receptor involvement, the main findings suggest that the
increase in amino acid uptake and protein synthesis are
mediated through the EGFR and involve the activation of
the ERK1/2 module of the MAPK pathway which in turn
activates RSK1/2 leading to an increase in the expression
of the L-type amino acid transporter LAT2.
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